Biotech Consortium to Accelerate Innovation Urges FDA for Early-Phase Rare Disease Workshop
2025-08-02
PubComNonGov2025-08-02
Carter Struck
WASHINGTON, Aug. 2 -- QurAlis, Cambridge, Massachusetts, on behalf of the Biotech Consortium to Accelerate Innovation (BCAI) and with backing from the EveryLife Foundation for Rare Diseases, has submi . . .
TARGETED NEWS SERVICE (founded 2004) features non-partisan 'edited journalism' news briefs and information for news organizations, public policy groups and individuals; as well as 'gathered' public policy information, including news releases, reports, speeches. For more information contact MYRON STRUCK, editor, editor@targetednews.com, Springfield, Virginia; 703/304-1897; https://targetednews.com
WASHINGTON, Aug. 2 -- QurAlis, Cambridge, Massachusetts, on behalf of the Biotech Consortium to Accelerate Innovation (BCAI) and with backing from the EveryLife Foundation for Rare Diseases, has submi . . .
TARGETED NEWS SERVICE (founded 2004) features non-partisan 'edited journalism' news briefs and information for news organizations, public policy groups and individuals; as well as 'gathered' public policy information, including news releases, reports, speeches. For more information contact MYRON STRUCK, editor, editor@targetednews.com, Springfield, Virginia; 703/304-1897; https://targetednews.com
Copyright © Targeted News Service, 2025